Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest GenVec Inc. Stories

2014-03-28 08:26:24

GAITHERSBURG, Md., March 28, 2014 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today reported financial results for the fourth quarter and year ended December 31, 2013. For the year ended December 31, 2013, the company reported a net loss of $10.0 million, or $0.77 per share, compared with a net loss of $14.1 million, or $1.09 per share, for the year ended December 31, 2012. GenVec ended the year with $6.1 million in cash, cash equivalents, and short-term investments. "Over the past six...

2014-03-21 08:24:49

GAITHERSBURG, Md., March 21, 2014 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) will report financial results for the fourth quarter and year ended December 31, 2013 on Friday, March 28, 2014, before the U.S. financial markets open. The announcement will be followed by a webcast and conference call at 10:00 a.m. EDT to discuss the company's fourth quarter and 2013 financial results as well as recent highlights and the 2014 business outlook. To listen to the live conference call,...

2014-03-13 08:29:25

GAITHERSBURG, Md., March 13, 2014 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) ("GenVec") today announced it has agreed to sell approximately $9 million of shares of its common stock to selected institutional investors in a registered direct offering at a price of $3.15 per share. In the offering, GenVec will issue approximately 2,870,000 shares of its common stock. The closing of the offering is expected to take place on or about March 18, 2014, subject to the satisfaction of...

2014-03-03 08:31:37

GAITHERSBURG, Md., March 3, 2014 /PRNewswire/ -- GenVec, Inc. (NASDAQ:GNVC) announced today that the Company will participate in the 26th Annual ROTH Conference being held March 9-12, 2014 in Dana Point, California. Douglas Swirsky, President and CEO of GenVec, will present a company overview on Monday, March 10, 2014 at 3:00 pm Pacific Daylight Time. A webcast of Mr. Swirsky's presentation will be available both live and on replay. The presentation will be available via webcast at...

2014-02-13 08:30:01

GAITHERSBURG, Md., Feb. 13, 2014 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that the company has achieved the third milestone in its collaboration with Novartis for the development of treatments for hearing and balance disorders. In January 2014, Novartis filed an Investigational New Drug (IND) application with the Food and Drug Administration (FDA) for the clinical development of CGF166, the lead product candidate under the collaboration. The IND was deemed...

2013-11-12 08:34:57

GAITHERSBURG, Md., Nov. 12, 2013 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced financial results for the third quarter and nine months ended September 30, 2013. Third Quarter and Recent Corporate Highlights -- Following an extensive review of the company's options and prospects, the board of directors withdrew the Plan of Complete Liquidation and Dissolution and approved a new operating strategy focused on maximizing the value of GenVec's...

2013-09-23 08:28:16

GAITHERSBURG, Md., Sept. 23, 2013 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that the previously disclosed putative class action lawsuit filed against the Company and certain of its current and former officers (the "Defendants") by the law firm of Brower Piven in the United States District Court for the District of Maryland has been dismissed with prejudice. No payment was made by any of the Defendants to the plaintiffs or their counsel in connection with the lawsuit....

2013-09-04 08:32:09

CEO Cynthia Collins to leave Company effective immediately; and CFO Douglas Swirsky to assume role of CEO GAITHERSBURG, Md., Sept. 4, 2013 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that its Board of Directors withdrew the Plan of Complete Liquidation and Dissolution for the Company previously adopted on May 24, 2013. The Company also announced that it will pursue a strategy focused on maximizing the value of its technology and assets, including its collaboration...

2013-03-22 08:24:37

GAITHERSBURG, Md., March 22, 2013 /PRNewswire/ -- Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the fourth quarter and year ended December 31, 2012. For the year ended December 31, 2012, the Company reported a net loss of $14.1 million, or $1.09 per share, compared with a net loss of $7.4 million, or $0.58 per share, for the year ended December 31, 2011. GenVec ended the year with $15.3 million in cash, cash equivalents, and short-term investments. "In 2012 we...

2013-03-15 08:26:40

GAITHERSBURG, Md., March 15, 2013 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) will report financial results for the fourth quarter and year ended December 31, 2012 on Friday, March 22, 2013, before the U.S. financial markets open. The announcement will be followed by a webcast and conference call at 10:00 a.m. EDT to discuss the company's fourth quarter and 2012 financial results and 2013 business outlook. To listen to the live conference call, please dial 877-558-0567 (U.S. or Canada) or...